Deep Dive In Vitiligo

Епизоде

• 
  Vitiligo in Uniform — Same Disease, Different System (ep. 77) 14.09.2026 22мин

  What changes when vitiligo puts on a uniform? The disease stays the same. Almost everything around it changes — from medical fitness and deployment to treatment access, military records, VA care, and disability claims. In this episode of Deep Dive in Vitiligo, we follow the patient journey from sick call to civilian care and examine where people, records, and responsibility can fall through the cracks. We also separate three questions that are too often mixed together: Can someone join? Can they remain in service? And did military service cause or aggravate the condition? We close with a preview of Massé World’s Honor Without Exception, a free symposium bringing service members, veterans, clinicians, researchers, and policymakers together in Miramar, Florida, on November 14, 2026. Same skin condition. Different rules. Much higher stakes. 📚 Prefer reading to listening? The full companion article expands on many of the themes discussed in this episode.
• 
  Dos ensayos de ruxolitinib en niños con vitiligo. Misma crema. Distinto mapa (Ep. 75) 07.09.2026 25мин

  Durante años, la crema aprobada se detenía a los 12. Los más pequeños se quedaban con el menú de siempre: corticoides, tacrolimus, luz si había hueco, y mucha espera. Eso empieza a cambiar. Hay dos ensayos de fase 3 con crema de ruxolitinib — Opzelura, si ya conoces el tubo — en niños con la forma más común de vitíligo. Protocolos de verdad. Centros de verdad. No un rumor de un grupo de padres. El matiz: no son el mismo estudio. Si los mezclas, una familia reserva viaje al continente equivocado. En este episodio de *Deep Dive in Vitiligo* ponemos los dos ensayos uno al lado del otro. Vas a escuchar: El ensayo norteamericano TRuE-ViP (NCT06548360): de 2 a 11 años, Estados Unidos y Canadá, unos 180 niños El ensayo internacional (NCT06804811, Incyte INCB18424-309): a partir de los 6 años, Argentina más 13 países europeos, unos 250 niños, sin centros en EE. UU. ni Canadá Lo que comparten: solo vitíligo no segmentario, un techo del 10% de superficie corporal, crema vehículo las primeras 24 semanas, la cara como medida principal en la semana 24, y la obligación de pausar otros tratamientos para el vitíligo, incluida la fototerapia Por qué un niño de 8 años puede cumplir la edad en los dos y no encajar en ninguno por código postal No suspendas un tratamiento que ya funciona porque en la misma semana aparecieron dos páginas de ensayo. Pregunta en el centro qué habría que pausar. Después llama al dermatólogo habitual del niño. Sí es una respuesta razonable. No también. La pregunta útil es qué protocolo — si es que alguno — encaja con este niño, en este país, con esta agenda.    
• 
  Two Pediatric Vitiligo Trials. Same Cream. Different Continents (Ep. 75) 07.09.2026 22мин

  For years, approved ruxolitinib cream has stopped at age 12. Younger children have had a much shorter menu: steroids, tacrolimus, light therapy if you can get a slot, and a lot of waiting. Now two Phase III studies are evaluating ruxolitinib cream in younger children. Its use for vitiligo in these age groups is investigational — researchers are still finding out how well it works and how safe it is. Real protocols. Real sites. Not a rumor from a parent group. Then the catch: they are not the same study. Mix them up and a family books the wrong continent. In this episode of Deep Dive in Vitiligo, we put the trials side by side. You’ll hear: North American trial TRuE-ViP (NCT06548360) — ages 2 to 11, United States and Canada The international trial (NCT06804811, Incyte INCB18424-309) — starts at age 6, Argentina plus 13 European countries, no U.S. or Canadian sites What they share: nonsegmental vitiligo, a 10% body-surface ceiling, active-versus-vehicle treatment during the first 24 weeks, facial scoring at Week 24, and some restrictions. Why an 8-year-old can fit both studies by age and neither by postcode. Do not stop a working routine because two trial pages appeared in the same week. Ask the site what would pause. Then call the child’s regular dermatologist. Yes is a reasonable answer. No is a reasonable answer. The useful question is which protocol — if either — fits this child, in this country, with this schedule. Both studies discussed in this episode are sponsored by Incyte Corporation. VRF provides patient education and study-awareness support related to Incyte pediatric vitiligo research under a paid services agreement. VRF does not determine study eligibility or recommend participation. 📚 Prefer reading to listening? These two companion articles expand on many of the themes discussed in this episode. Vitiligo Study For Children Ages 2–11 in USA and Canada  Vitiligo Study For Children Ages 6-11, International
• 
  Fit, Friction, and Flares: Finding the Right Glove for Hand Vitiligo (Ep. 74) 31.08.2026 22мин

  Most people think gloves are simple: put them on, protect your hands, move on with life. Unfortunately, your skin didn’t get that memo. In this episode of Deep Dive in Vitiligo, we explore the surprisingly complicated world of work gloves, hand dermatitis, chemical leukoderma, and the Koebner phenomenon. Why do some gloves trigger itching, cracking, or irritation? Why can friction matter almost as much as chemicals? And why are many dermatologists quietly steering patients toward accelerator-free nitrile gloves? We compare latex, vinyl, and nitrile options, discuss cotton and silk liners, tackle the rise of biodegradable “eco-friendly” gloves, and explain how a simple choice at the hardware store or workplace can affect long-term hand health. No fear-mongering. No glove industry conspiracies. Just practical advice to help your hands do their job without becoming part of the problem. Because the best glove is supposed to protect your skin — not give it a new hobby.  📚 Prefer reading to listening? The companion article expands on many of the themes discussed in this episode.
• 
  The Prescription You Won’t Find in a Pharmacy: Vitiligo Books for Kids (Ep. 73) 24.08.2026 13мин

  Not every vitiligo lesson has to come from a doctor’s office. In this episode of Deep Dive in Vitiligo, we explore some of the best children’s books about vitiligo—from heartfelt stories of self-acceptance to practical tools that help kids explain their skin to friends, classmates, and even themselves. We discuss how books can build confidence long before a child learns the medical terminology, and which titles are actually worth adding to your family library. Whether you’re a parent, grandparent, teacher, healthcare professional, or simply looking for a thoughtful gift, this episode offers a guided tour through the growing world of vitiligo literature for young readers. Because sometimes a story can do what a prescription cannot. ✨ 📚 Prefer reading to listening? The companion article expands on many of the themes discussed in this episode, with links to find these titles online.  
• 
  Vitamin D Megadoses for Vitiligo: Hope, Hype, or Hospital Trip? (Ep. 72) 17.08.2026 22мин

  Vitamin D matters in vitiligo. Megadoses? That’s where things get interesting — and risky. In this episode, we unpack the hype around high-dose vitamin D, the Coimbra Protocol, and the small Brazilian study that made patients pay attention. We cover the possible immune benefits, the real safety concerns — hypercalcemia, kidney stones, strict monitoring — and why correcting a deficiency is not the same as taking massive doses. Promising biology. Preliminary evidence. Poor safety. No miracle-cure fireworks. 📚 Prefer reading to listening? The full companion article expands on many of the themes discussed in this episode.  
• 
  From Dr. Google to Dr. AI: The Great Cognitive Surrender (Ep. 71) 10.08.2026 23мин

  Patients used to Google their symptoms. Now they ask AI what the hell to do next. In this episode of Deep Dive in Vitiligo, we unpack “cognitive surrender” — that quiet moment when people stop wrestling the information jungle and just hand the steering wheel to an AI companion. For pharma, the old playbook is dead. Forget billboards, keywords, and glossy websites. The new arena is whether the AI understands, trusts, and actually recommends your therapy when a patient asks: “What are my real options for this vitiligo?” Less advertising. More droid advisor. Welcome to the future of pharmaceutical marketing — where the most important customer might not even be human anymore.   📚 Prefer reading to listening? The full companion article expands on many of the themes discussed in this episode.
• 
  Splinters, Ridges & Half-Moons: The Secret Life of Vitiligo Nails (Ep. 70) 03.08.2026 25мин

  Nails may seem like an unlikely place to look for clues about vitiligo — but science says otherwise. In this episode of Deep Dive in Vitiligo, we cut through the hype on the real, usually mild, connection between vitiligo and nail changes. Melanocytes live in the nail matrix too, so the same immune activity that affects skin pigment may sometimes leave tiny traces: vertical ridges, leukonychia, splinter hemorrhages, brittle nails, missing half-moons, or changes visible only through dermoscopy. We unpack the latest studies, explain what these findings may mean for patients, and discuss when nail changes deserve a closer look — and when they’re probably just part of being human. No panic. No self-diagnosis spirals. Just a fascinating look at one of the most overlooked corners of vitiligo science. 🔍💅 📚 Prefer reading to listening? The full companion article expands on many of the themes discussed in this episode.
• 
  Red Wine, Black Coffee, and Why Your Antioxidant Pills Are Ghosting You (Ep. 69) 27.07.2026 20мин

  We’ve all seen the headlines: red wine might reduce vitiligo risk. Coffee keeps showing up as protective in the data. Berries, tea, and the usual Mediterranean suspects all look suspiciously useful. Sounds like good news — until you remember the supplement aisle packed with “super antioxidant” bottles that somehow never quite deliver. In this episode, we cut through the noise. Genetic studies hint at real signals from whole-food polyphenols and the messy, living matrix that comes with them — not lonely molecules trapped in capsules. We talk oxidative stress, why biology prefers a Swiss watch over a single gear, moderation (yes, even with wine), and why Prof. Torello Lotti’s famous final slide with a glass of Chianti still hits different. No miracle cures. No wellness hype. Just the practical, slightly inconvenient truth about food, context, and living like a human instead of a biochemistry experiment. Pour yourself something real — or don’t — and join the conversation.   📚 Prefer reading to listening? Two companion articles expand on many of the themes discussed in this episode:  Red Wine and Vitiligo: Helpful, Harmful, or Just Humans Looking for Good News? Why Berries, Coffee and Wine Work Better Than Antioxidant Capsules  
• 
  Herbs That Secretly Bleach Your Skin (Ep. 68) 20.07.2026 21мин

  Natural does not always mean helpful. In this episode of Deep Dive in Vitiligo, we flip the usual herbal medicine question on its head. Instead of asking "which herbs may help vitiligo", we ask something more uncomfortable: could some popular “immune boosters” be quietly working against repigmentation? We explore how herbs like ginseng, Bacopa monnieri, and licorice root may affect melanin production, tyrosinase activity, and the same pigment pathways many vitiligo treatments are trying to restore. This is not an anti-herb episode. It is a pro-chemistry episode. Because your melanocytes do not care whether something is natural, ancient, or wrapped in nice green packaging. They respond to biology. If you take supplements, drink herbal teas, use adaptogens, or apply “brightening” skincare products while treating vitiligo, this episode is worth your attention.   📚 Prefer reading to listening? The full companion article expands on many of the themes discussed in this episode.
• 
  Vitiligo, Antiperspirants & Angry Underarms — Is Your Deodorant a Trigger? (Ep. 67) 13.07.2026 24мин

  Could your deodorant be making vitiligo worse? It’s a question that lands in our inbox surprisingly often — and one that turns out to be more complicated than a simple yes or no. In this episode of Deep Dive in Vitiligo, we explore the science behind deodorants, antiperspirants, fragrance allergies, chemical leukoderma, and why underarm skin may deserve more attention than most of us give it. There’s no solid evidence that ordinary deodorants or antiperspirants cause vitiligo. If your deodorant works, feels invisible, and causes no problems, carry on. But if it burns, itches, triggers eczema, or seems connected to new patches, your skin may be trying to tell you something. Tune in for the latest 2026 regulatory updates, including expanded EU fragrance labeling, the truth about the “whole-body deodorant” trend, and a practical routine to help keep your underarms calm. You’ll get a dead-simple testing protocol, the red-flag signs to stop yesterday, and a practical routine that respects real skin instead of wellness theater.   📚 Prefer reading to listening? The full companion article expands on many of the themes discussed in this episode.
• 
  From Karma to Bakuchi: What Ancient Wisdom and Modern Science Say About Vitiligo (Ep. 66) 06.07.2026 19мин

  In this World Vitiligo Day 2026 Special, we explore the raw territory where autoimmune disease, chronic stress, ancient traditions, and modern science collide. From karma and samskaras in India to ayahuasca ceremonies deep in the Amazon, from Bakuchi in Ayurveda to T-cells and JAK inhibitors, we examine how cultures across time have tried to explain — and heal — vitiligo. Inside the episode: - Why karma isn’t cosmic punishment, but a useful lens on patterns, stress, and change- The surprising overlap between ancient wisdom and modern neuroscience- My personal nights with Shuar healer Cezario in the Ecuadorian rainforest — and what his ayahuasca diagnosis actually delivered- What Ayurveda and traditional Chinese medicine can teach us, and why heavy-metal warnings still matter- Why stress plays a role, but isn’t the whole story- How JAK inhibitors and modern immunology are quietly changing the game This isn’t about picking sides between science and spirituality. It’s about refusing false choices. Humans have always searched for meaning in suffering. The future of vitiligo care needs both evidence and humility. If you’ve ever wondered whether healing involves more than repigmentation, this one’s for you.   📚 Prefer reading to listening? The full companion article is available on the VRF website and expands on many of the themes discussed in this episode.   Disclaimer: This episode explores cultural traditions and emerging scientific hypotheses for educational purposes and does not constitute medical advice. Always consult a qualified healthcare professional.
• 
  50 Years Later: What Became of the National Vitiligo Control Act? (Ep. 64) 22.06.2026 21мин

  What if the modern vitiligo movement began decades earlier than most people realize? In this episode, we travel back nearly 50 years to explore one of the most forgotten chapters in vitiligo history: the National Vitiligo Control Act. Long before social media, celebrity advocates, World Vitiligo Day, or FDA-approved treatments, a small group of advocates was already trying to bring vitiligo into the national spotlight. We examine a remarkable story behind legislative effort, why it failed to become law, and how many of its goals eventually became reality anyway. If you’ve ever wondered how the vitiligo movement got here, this episode is a fascinating place to start. 📚 Prefer reading to listening? The full companion article and expands on many of the themes discussed in this episode.  
• 
  Sunlight and Sunscreen Paradox in Vitiligo (Ep. 63) 15.06.2026 23мин

  Is your sunscreen doing more harm than good? UV protection is non-negotiable — especially when your depigmented skin has zero natural melanin shield — but FDA absorption studies, benzene recalls, and endless headlines have turned a simple tool into a source of anxiety. We cut through the fog: chemical vs. mineral realities, why chasing SPF 100 often backfires, and how to protect yourself smartly without joining the panic chorus. No slogans, just the messy science and what actually matters if you burn faster than everyone else. Essential summer listening if that bottle on your shelf now feels more complicated than it should. 📚 Prefer reading to listening? The full companion article expands on many of the themes discussed in this episode.
• 
  The Vitiligo Corporate Trench Map (Ep. 62) 08.06.2026 24мин

  The cavalry has finally arrived — but now you need a map. In this fast-paced Deep Dive in Vitiligo briefing, VRF CEO Yan Valle explores the forces reshaping the vitiligo landscape—from pharmaceutical giants and emerging biotech companies to AI-powered research, teledermatology, and the growing role of India and China in global innovation. Inside this episode: The Pioneers vs. The Giants: How a handful of early innovators opened the door for researchers and pharmaceutical companies. The Global Shift: Why the next wave of vitiligo innovation may be driven as much by India and China as by traditional biotech hubs. The Bulldozers Arrive: How companies like Incyte, AbbVie, and Pfizer changed the field from a fragile research niche into a serious dermatology market. For years, the biggest challenge was getting vitiligo noticed. Today, the challenge is knowing where to go next. We have officially entered the Era of Navigation. If you want a clearer picture of where the science, the investment, and the opportunities are moving, this episode is your map.   📚 Prefer reading to listening? The full companion article, “The Vitiligo Corporate Trench Map,” is available on the VRF website and expands on many of the themes discussed in this episode.  
• 
  An Entire History Of the World Vitiligo Day (Ep. 61) 05.06.2026 21мин

  Discover the extraordinary, little-known story behind World Vitiligo Day, observed every year on June 25. In this episode, we unpack the remarkable rise of World Vitiligo Day (WVD). Based on the comprehensive retrospective by the Vitiligo Research Foundation, we explore the grassroots efforts of advocates in India, the United States, and Nigeria, the unexpected role of Michael Jackson’s global fanbase, and how a network-centric movement helped push vitiligo into the scientific, public-health, and legislative spotlight.   📚 Prefer reading to listening? The full companion article is available on the VRF website and expands on many of the themes discussed in this episode.
• 
  The Jackson-Thomas-Harlow Effect On Vitiligo (Ep. 60) 03.06.2026 19мин

  The Jackson-Thomas-Harlow Effect describes how visibility, storytelling, and cultural representation can reshape public understanding of vitiligo. In this episode of Deep Dive in Vitiligo, we look at how: Michael Jackson made vitiligo globally known, Lee Thomas gave it a courageous and deeply human public voice, and Winnie Harlow helped turn visible difference into mainstream representation. We also discuss how World Vitiligo Day transformed that visibility into a global advocacy movement — connecting patients, doctors, researchers, and communities around the world. A sharp look at medicine, media, and why human faces often change minds faster than facts. 🎙️ 📚 Prefer reading to listening? The full companion article, The Jackson, Thomas, Harlow Effect on Vitiligo is available on the VRF website and expands on many of the themes discussed in this episode.
• 
  Google Doodle for World Vitiligo Day 2026 (Ep. 59) 02.06.2026 16мин

  Google sees billions of searches. But what if, for one day, it helped the world see vitiligo? In this episode of Deep Dive in Vitiligo, we explore the renewed campaign to bring a Google Doodle to World Vitiligo Day on June 25, 2026. Past attempts did not succeed. This year, the strategy shifts from emotional appeals to raw tech logistics. We discuss how the vitiligo community is mobilizing for a coordinated digital push with one simple goal: feed Google’s automated intake systems with enough structured public signal. By saturating the web with a clear, unified message linking “World Vitiligo Day” directly to “Google Doodle,” the campaign aims to make the connection impossible to miss — and shine a literal ray of light onto a community that has spent too long in the shadows. From WVD’s grassroots beginnings in 2011 to its 2026 return to Chandigarh under the theme “From Stigma to Strength,” this is a story about symbols, recognition, and a patient community learning how to speak the language of the platforms that shape visibility today. Continue reading: Google Doodle for World Vitiligo Day 2026
• 
  Deep Dive in Vitiligo Is Back — And Yes, AI Made Us Busier (Ep. 58) 02.06.2026 19мин

  After a brief hiatus, the Deep Dive in Vitiligo podcast returns with a packed lineup of new episodes covering vitiligo science, lifestyle, advocacy, and technology. In this update, Yan Valle explains where the podcast has been, why AI didn’t save nearly as much time as promised, and what’s coming next—including the Jackson–Thomas–Harlow Effect children’s books coffee and red wine smoking and vaping vitamin D megadosing career success nail changes deodorants and the growing role of artificial intelligence in healthcare. The voices may be AI. The research, writing, editing, and judgment remain entirely human. Subscribe now and join us for a new season of conversations at the intersection of skin, science, technology, and the human experience.
• 
  The State of Vitiligo 2025: A Fast-Moving Field With Slow-Moving Funding (Ep. 57) 31.12.2025 17мин

  In this closing 2025 episode, we unpack four decades of National Institute of Health (NIH) data, compare vitiligo’s budget to other autoimmune and skin diseases, and explain the “industry twist”: tiny public dollars helped build the science, while the commercial market is now booming. We also look at the big paradox: vitiligo research helped spark major ideas in modern medicine (think immune pathways that later shaped blockbuster therapies), yet the shared infrastructure vitiligo now needs — US-based biobanks, registries, and longitudinal cohorts — remains fragmented. Meanwhile, the commercial side is moving fast, with a billion-dollar market and crowded pipelines. Read the full report in two parts: The Vitiligo Paradox – Common Disease, Rare Funding Who Gets to Do Vitiligo Science?